Fundraising Fox
Nula Therapeutics
St. Petersburg, US · Founded 2021 · Delaware corporation · 4 employees on LinkedIn · 2 known investors
Find your way into Nula Therapeutics
Sign up to see every warm intro you have to Nula Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Nula Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
CS
Christopher ShepardChief Executive Officer, Board of Directors, Co-FounderChristopher Shepard is a liver pathologist and drug development specialist with expertise in metabolic disease and oncology who founded Nula Therapeutics, where he serves as Executive Officer and Director. He previously held positions at Apollo Ventures, MIT's Biological Engineering Group, and as a Principal Investigator for the Department of Defense's Breast Cancer Research Program.
JR
Jarod RutledgeNamed on SEC filing
Board
Investors · 2
Korify Capitallisted by Korify Capital
How we know: Korify Capital's portfolio page · Not right? Tell us
Apollo Health VenturesreportedBerlin
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$7.4M disclosed across 1 round · 2026
▶$7.4MraisedMar 2026 · 7 investors · BiotechnologyRule 506(b)
▶$7.4MraisedMar 2026 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jarod RutledgeDirector
- Christopher ShepardExecutive Officer, Director
- Nils ReggeDirector
- Offering amount
- $7.4M
- Amount sold
- $7.4M
- First sale
- Feb 2026
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Nula Therapeutics's investors?
- Nula Therapeutics's investors include Korify Capital, Apollo Health Ventures.
- How much funding has Nula Therapeutics raised?
- Nula Therapeutics has disclosed $7.4M raised across 1 round.
- Where is Nula Therapeutics headquartered?
- Nula Therapeutics is headquartered in St. Petersburg, US.